Company Analysis - Cephalon Inc.

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.( http://www.companyprofilesandconferences.com/report/Company-Analysis-Cephalon-Inc.html )
 
 The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.
 
 Report Highlights
 
 - Provides a comprehensive version of the company's performance
 - Offers key financial data, ratio and SWOT analysis
 - Tracks major M&A trends and developments
 - Business Profile, SWOT analysis and financial information on top five competitors
 - View on the company by our analysts
 - Supplemented with graphs and tabular information wherever necessary
 
 Table of Contents :
 
 1. Company Overview
 1.1 History
 1.2 Business Overview
 1.3 Organizational Structure
 1.4 Major Mergers & Acquisitions
 1.5 Ticker Codes at various Stock Exchange Listings
 1.6 Management Profile
 2. Product & Services
 2.1 Product & Services - An Overview
 2.2 Revenue & Income Summary by Geographical Distribution
 2.3 Revenue & Income Summary by Business Division
 3. Financial Information for the Fiscal Year
 3.1 Financial Summary for the Fiscal Year
 3.2 Breakup of Revenue & Sales Trends
 3.3 Ratio & Market Indicators
 3.4 Earning & Income Estimates
 3.5 Stock Analysis
 4. SWOT Analysis
 4.1 Strength
 4.2 Weakness
 4.3 Opportunity
 4.4 Threats
 5. Top Competitors (Key Financials & SWOT Analysis)
 5.1 Bayer AG
 5.2 Johnson & Johnson
 5.3 Novartis AG
 5.4 GlaxoSmithKline
 6. Analyst View
 
 List of Figures:
 
 Figure 2-1: Cephalon Inc. - Revenue by Geographical Distribution (%), 2009
 Figure 2-2: Cephalon Inc. - Revenue by Business Division (Million US$), 2008 & 2009
 Figure 3-1: Cephalon Inc. - Stock Chart
 
 List of Tables:
 
 Table 1-1: Cephalon Inc. - Major Mergers & Acquisitions (2000 to 2011)
 Table 1-2: Cephalon Inc. - Ticker Codes at various Stock Exchange
 Table 1-3: Cephalon Inc. - Key Management People
 Table 3-1: Cephalon Inc. - Financial Overview (Million US$), 2009
 Table 3-2: Cephalon Inc. - Break-up of Revenue & Sales (Million US$), 2007-2009
 Table 3-3: Cephalon Inc. - Key Financial Ratios (2007-2009)
 Table 3-4: Cephalon Inc. - Earning & Income Estimates (Million US$), 2007-2009
 Table 5-1: Bayer AG - Key Financials (Million US$), 2007-2009
 Table 5-2: Bayer AG - SWOT Analysis
 Table 5-3: Johnson & Johnson - Key Financials (Million US$), 2007-2009
 Table 5-4: Johnson & Johnson - SWOT Analysis
 Table 5-5: Novartis AG - Key Financials (Million US$), 2007-2009
 Table 5-6: Novartis AG - SWOT Analysis
 Table 5-7: GlaxoSmithKline - Key Financials (Million US$), 2007-2009
 Table 5-8: GlaxoSmithKline - SWOT Analysis
 
 For more information kindly visit :
 http://www.companyprofilesandconferences.com/report/Company-Analysis-Cephalon-Inc.html
 
 Or
 
 Contact us at :
 
 Company Profiles and Conferences
 Flat A-1901/02, 19th floor,
 Kshitij Building,Sec-19,
 Palm Beach Road, Sanpada,
 Navi Mumbai - 400705, India.
 Phone : +91 22 2756 1536
 Fax : +91 22 2757 9131
 E-mail : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com